Kidney Transplant Unit - Department of Internal Medicine - Faculty of Medicine, Ain Shams University Hospitals, Cairo, Egypt.
BMC Nephrol. 2023 Nov 7;24(1):328. doi: 10.1186/s12882-023-03379-9.
Infection after a kidney transplant is a serious cause of morbidity and mortality. Weighing the risks and benefits of immunosuppression is of paramount importance for patient wellbeing and transplant survival.
This is a prospective observational study exploring the variety of bacterial, viral and fungal infections occurring within the first year of living related kidney transplantation in a young transplant cohort. Fifty-one kidney transplant recipients (KTR) between the age of 18 and 45 who had a kidney transplant between Jan 2020 and Jan 2022 were enrolled and followed up for one year. Primary outcome was the occurrence of infection.
Twenty-four patients (47%) recorded a collective 33 episodes of infection. Seven patients had repeated infections and 17 had single infections. Twenty-seven patients had an uneventful year with no infections recorded. Commonest infection was lower urinary tract infection (UTI) (27.3%) followed by SARS-COV2 and Herpes Zoster (15.2%). The commonest pathogens causing lower UTI were Escherichia coli (E coli) (21.2%) and Klebsiella (18.2%). Median Tacrolimus level was (7.8) ng/ml in KTR with infection and (8.95) ng/ml in KTR without infection, p = 0.21. Median Haemoglobin (IQR) was (10.2) g/dl (7.8-14) gm/dl in KTR with infection compared to (10.8) g/dl (7.3-15.3) in KTR without infection odds ratio (OR) = 0.78, confidence interval (CI) (0.5-1.1); p = 0.16.In KTR with infection 25% had donors above the age of 60 compared to 11% in KTR without infection ( OR 2.6,CI (0.5-12), p = 0.2). Post transplant diabetes (PTDM) occurred in (25%) in KTR with infection compared to those without, but that was not statistically significant p = 0. 365.In KTR without infection, 59.3% had a preemptive transplant compared to 20.8% in the group with infection (OR = 0.18; 95% CI: 0.052-0.631; p = 0.007). Median tacrolimus was 7.8 ng/ml in KTR with single infection compared to 7.7 ng/ml in KTR with repeated infections.
This study shows that the commonest infection occurring in the first-year post kidney transplant was lower urinary tract infection followed by SARS-COV2 and Herpes Zoster. There was no difference in trough tacrolimus or haemoglobin levels between KTR who developed infection with those who did not.
肾移植后的感染是导致发病率和死亡率的严重原因。权衡免疫抑制的风险和益处对患者的健康和移植的存活率至关重要。
这是一项前瞻性观察研究,旨在探讨年轻移植队列中活体相关肾移植后一年内发生的各种细菌、病毒和真菌感染。2020 年 1 月至 2022 年 1 月期间,我们招募了 51 名年龄在 18 至 45 岁之间的肾移植受者(KTR),并对其进行了为期一年的随访。主要结局是感染的发生。
24 名患者(47%)共记录了 33 次感染。7 名患者出现重复感染,17 名患者出现单次感染。27 名患者无感染发生。最常见的感染是下尿路感染(UTI)(27.3%),其次是 SARS-COV2 和带状疱疹(15.2%)。引起下尿路感染的最常见病原体是大肠埃希菌(E coli)(21.2%)和克雷伯菌(18.2%)。感染 KTR 的他克莫司中位数水平为(7.8)ng/ml,无感染 KTR 的他克莫司中位数水平为(8.95)ng/ml,p=0.21。感染 KTR 的血红蛋白中位数(IQR)为(10.2)g/dl(7.8-14)g/dl,无感染 KTR 的血红蛋白中位数(IQR)为(10.8)g/dl(7.3-15.3)g/dl,感染 KTR 的比值比(OR)为 0.78,置信区间(CI)(0.5-1.1);p=0.16。感染 KTR 中有 25%的供者年龄大于 60 岁,而无感染 KTR 中有 11%(OR 2.6,CI(0.5-12),p=0.2)。感染 KTR 中有 25%发生了移植后糖尿病(PTDM),而无感染 KTR 中有 11%,但差异无统计学意义,p=0.365。在无感染 KTR 中,59.3%的患者接受了抢先移植,而感染 KTR 中只有 20.8%(OR=0.18;95%CI:0.052-0.631;p=0.007)。单次感染 KTR 的他克莫司中位数为 7.8ng/ml,而重复感染 KTR 的他克莫司中位数为 7.7ng/ml。
本研究表明,肾移植后第一年内最常见的感染是下尿路感染,其次是 SARS-COV2 和带状疱疹。发生感染的 KTR 与未发生感染的 KTR 之间的他克莫司谷浓度或血红蛋白水平无差异。